Skip to main content
Caplight Logo









Terran Biosciences

Terran Biosciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://terranbiosciences.com/

Last Round

Series B

Feb 1, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Terran Biosciences is a biotechnology company that develops a platform for therapeutics and technologies for patients with neurological and psychiatric diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

psychedelic therapeuticsCNS therapeuticsbiotech platformpsychedelic medicinemedical imaging AIprodrugsdrug reformulationAI diagnostics505(b)(2) pathwaysoftware as a medical deviceSaMDnon-hallucinogenic psychedelicsneuromelanin MRIdiagnostic biomarkerempathogen therapeuticsGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terran Biosciences Comparables

Compare Terran Biosciences with similar companies based on industry and business-model similarity.

Terran Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AtaiBeckley Inc.
77%
Definium Therapeutics
77%
Gilgamesh Pharmaceuticals
76%

Terran Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 1, 2024
Series BFeb 1, 2024

Terran Biosciences Investors

Notable investors and investment history

Terran Biosciences investors
InvestorRounds
Magnetic VenturesSeries B
Catalytic Impact FoundationSeries B
Noetic FundSeries B
Astir VenturesSeries B
Transhuman CapitalSeries B
Magna FilisSeries B
The Brkfst ClubSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 119% MoM, reaching 1.7K.

  • May 17, 2026

    Monthly visitors grew 33% MoM.

Terran Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terran Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terran Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2017
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?